APA (7th ed.) Citation

M, S., B, S., V, Z., D, Z., H, P., K, R., . . . P, C. (2018). CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction. Acta haematologica, 139(4), 228. https://doi.org/10.1159/000489483

Chicago Style (17th ed.) Citation

M, Skerget, Skopec B, Zadnik V, Zontar D, Podgornik H, Rebersek K, Furlan T, and Cernelc P. "CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction." Acta Haematologica 139, no. 4 (2018): 228. https://doi.org/10.1159/000489483.

MLA (9th ed.) Citation

M, Skerget, et al. "CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction." Acta Haematologica, vol. 139, no. 4, 2018, p. 228, https://doi.org/10.1159/000489483.